Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for Readers

    Page :A6

    
• • ·Correction

    Page :794

    

• Curriculum in Cardiology

  • ·Efficacy of exercise-based cardiac rehabilitation post–myocardial infarction: A systematic review and meta-analysis of randomized controlled trials

    Page :571

    Patrick R. Lawler, Kristian B. Filion, Mark J. Eisenberg

    Résumé Résumé Plan Plan  
  • ·Measuring and targeting aldosterone and renin in atherosclerosis—A review of clinical data

    Page :585-596

    Marieke A. Hillaert, Eef G. Lentjes, Farzin Beygui, Hans Kemperman, Folkert W. Asselbergs, Hendrik M. Nathoe, Pierfrancesco Agostoni, Michiel Voskuil, Fabrice Ivanes, Brigitte Jude, Michel E. Bertrand, Gerard Pasterkamp, Yolanda van der Graaf, Pieter A. Doevendans, Gilles Montalescot, Eric Van Belle

    Résumé Résumé Plan Plan  

• Trial Design

  • ·Interleukin-1? inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

    Page :597-605

    Paul M Ridker, Tom Thuren, Andrew Zalewski, Peter Libby

    Résumé Résumé Plan Plan  
  • ·Outcomes registry for better informed treatment of atrial fibrillation: Rationale and design of ORBIT-AF

    Page :606

    Jonathan P. Piccini, Elizabeth S. Fraulo, Jack E. Ansell, Gregg C. Fonarow, Bernard J. Gersh, Alan S. Go, Elaine M. Hylek, Peter R. Kowey, Kenneth W. Mahaffey, Laine E. Thomas, Melissa H. Kong, Renato D. Lopes, Roger M. Mills, Eric D. Peterson

    Résumé Résumé Plan Plan  
  • ·Study design and rationale for the Stabilization of pLaques usIng Darapladib—Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome

    Page :613

    Michelle L. O'Donoghue, Eugene Braunwald, Harvey D. White, Patrick Serruys, Ph. Gabriel Steg, Judith Hochman, Aldo P. Maggioni, Christoph Bode, Douglas Weaver, Joel L. Johnson, Greg Cicconetti, Mary Ann Lukas, Elizabeth Tarka, Christopher P. Cannon

    Résumé Résumé Plan Plan  
  • ·EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE) : A cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome

    Page :620

    William B. White, George L. Bakris, Richard M. Bergenstal, Christopher P. Cannon, William C. Cushman, Penny Fleck, Simon Heller, Cyrus Mehta, Steven E. Nissen, Alfonso Perez, Craig Wilson, Faiez Zannad

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC): Results from phase I and scientific opportunities in phase II

    Page :627

    Barbara L. Kroner, H. Eser Tolunay, Craig T. Basson, Reed E. Pyeritz, Kathryn W. Holmes, Cheryl L. Maslen, Dianna M. Milewicz, Scott A. LeMaire, Tabitha Hendershot, Patrice Desvigne-Nickens, Richard B. Devereux, Harry C. Dietz, Howard K. Song, Danny Ringer, Megan Mitchell, Jonathan W. Weinsaft, William Ravekes, Victor Menashe, Kim A. Eagle

    Résumé Résumé Plan Plan
  • ·Prospective study of infective endocarditis from a developing country

    Page :633-638

    Ravi S. Math, Gautam Sharma, Shyam Sunder Kothari, Mani Kalaivani, Anita Saxena, Arkalgud Sampath Kumar, Vinay K. Bahl

    Résumé Résumé Plan Plan
  • ·Prognostic value of serial measurements of highly sensitive cardiac troponin I in stable outpatients with nonischemic chronic heart failure

    Page :639-645

    Chiho Kawahara, Takayoshi Tsutamoto, Hiroshi Sakai, Keizo Nishiyama, Masayuki Yamaji, Masanori Fujii, Takashi Yamamoto, Minoru Horie

    Résumé Résumé Plan Plan  
  • ·The impact of left ventricular size on response to cardiac resynchronization therapy

    Page :646-653

    John Rickard, Danielle M. Brennan, David O. Martin, Eileen Hsich, W.H. Wilson Tang, Bruce D. Lindsay, Randall C. Starling, Bruce L. Wilkoff, Richard A. Grimm

    Résumé Résumé Plan Plan  
  • ·A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction

    Page :654

    Thomas J. Povsic, Christopher M. O'Connor, Timothy Henry, Andrew Taussig, Dean J. Kereiakes, F. David Fortuin, Alan Niederman, Richard Schatz, Richard Spencer, Douglas Owens, Missy Banks, Diane Joseph, Rhonda Roberts, John H. Alexander, Warren Sherman

    Résumé Résumé Plan Plan  
  • ·Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: The HORIZONS-AMI trial

    Page :663-670

    Damian J. Kelly, Tony Gershlick, Bernhard Witzenbichler, Giulio Guagliumi, Martin Fahy, George Dangas, Roxana Mehran, Gregg W. Stone

    Résumé Résumé Plan Plan  
  • ·Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging

    Page :671-677

    Jay H. Traverse, Timothy D. Henry, Lemuel A. Moye'

    Résumé Résumé Plan Plan
  • ·In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)

    Page :678-684

    Daniel F. Pauly, B. Delia Johnson, R. David Anderson, Eileen M. Handberg, Karen M. Smith, Rhonda M. Cooper-DeHoff, George Sopko, Barry M. Sharaf, Sheryl F. Kelsey, C. Noel Bairey Merz, Carl J. Pepine

    Résumé Résumé Plan Plan  
  • ·Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both

    Page :685-691

    Amil M. Shah, Chung-Lieh Hung, Sung Hee Shin, Hicham Skali, Anil Verma, Jalal K. Ghali, Lars Køber, Eric J. Velazquez, Jean L. Rouleau, John J.V. McMurray, Marc A. Pfeffer, Scott D. Solomon

    Résumé Résumé Plan Plan
  • ·Improvement in use of anticoagulation therapy in patients with ischemic stroke: Results from Get With The Guidelines–Stroke

    Page :692

    William R. Lewis, Gregg C. Fonarow, Maria V. Grau-Sepulveda, Eric E. Smith, Deepak L. Bhatt, Adrian F. Hernandez, DaiWai Olson, Eric D. Peterson, Lee H. Schwamm

    Résumé Résumé Plan Plan  
  • ·Cluster-randomized trial to evaluate the effects of a quality improvement program on management of non–ST-elevation acute coronary syndromes: The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS)

    Page :700

    Marcus D. Flather, Daphne Babalis, Jean Booth, Alfredo Bardaji, Jacques Machecourt, Grzegorz Opolski, Filippo Ottani, Héctor Bueno, Winston Banya, Anthony R. Brady, Mats Bojestig, Bertil Lindahl

    Résumé Résumé Plan Plan  
  • ·Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia

    Page :708-716

    Hayes M. Dansky, Daniel Bloomfield, Patrice Gibbons, Sherry Liu, Christine McCrary Sisk, Diane Tribble, James M. McKenney, Thomas W. Littlejohn, Yale Mitchel

    Résumé Résumé Plan Plan  
  • ·Adherence to the Mediterranean diet in relation to acute coronary syndrome or stroke nonfatal events: A comparative analysis of a case/case-control study

    Page :717-724

    Christina-Maria Kastorini, Haralampos J. Milionis, Aggeliki Ioannidi, Kallirroi Kalantzi, Vassilios Nikolaou, Konstantinos N. Vemmos, John A. Goudevenos, Demosthenes B. Panagiotakos

    Résumé Résumé Plan Plan
  • ·Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease

    Page :725

    Salim S. Virani, LeChauncy D. Woodard, Supicha S. Chitwood, Cassie R. Landrum, Tracy H. Urech, Degang Wang, Jeffrey Murawsky, Christie M. Ballantyne, Laura A. Petersen

    Résumé Résumé Plan Plan  
  • ·Prasugrel overcomes high on-clopidogrel platelet reactivity in chronic coronary artery disease patients more effectively than high dose (150 mg) clopidogrel

    Page :733-739

    Dimitrios Alexopoulos, Ioanna Xanthopoulou, Periklis Davlouros, Theodora-Eleni Plakomyti, Aggeliki Panagiotou, Eleni Mavronasiou, George Hahalis

    Résumé Résumé Plan Plan  
  • ·A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease

    Page :740-747

    Sebastian Kufner, Antoinette de Waha, Fabrizio Tomai, Seong-Wook Park, Seung-Whan Lee, Do-Sun Lim, Moo Hyun Kim, Anders M. Galloe, Michael Maeng, Carlo Briguori, Alban Dibra, Albert Schömig, Adnan Kastrati

    Résumé Résumé Plan Plan  
  • ·Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

    Page :748

    John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, Patrick Parfrey, Hans-Henrik Parving, Robert M. Toto, Scott D. Solomon, Marc A. Pfeffer

    Résumé Résumé Plan Plan  
  • ·Cognitive decline and ischemic microlesions after coronary catheterization. A comparison to coronary artery bypass grafting

    Page :756-763

    Niko Schwarz, Markus Schoenburg, Helge Möllmann, Sabrina Kastaun, Manfred Kaps, Georg Bachmann, Gebhard Sammer, Christian Hamm, Thomas Walther, Tibo Gerriets

    Résumé Résumé Plan Plan  
  • ·Downstream coronary effects of drug-eluting stents

    Page :764

    Richard A. Krasuski, George M. Cater, Ganesh P. Devendra, Kathy Wolski, Mehdi H. Shishehbor, Steven E. Nissen, Carlos Oberti, Stephen G. Ellis

    Résumé Résumé Plan Plan  
  • ·Appropriateness use criteria for transthoracic echocardiography: Relationship with radiology benefit managers preauthorization determination and comparison of the new (2010) criteria to the original (2007) criteria

    Page :772-779

    Howard J. Willens, Robert C. Hendel, Francine R. Inhaber, Simon C. Chakko, Cheryl Postel, Tahira Hasan, Fareed Mohammed

    Résumé Résumé Plan Plan  
  • ·Effect of informed consent format on patient anxiety, knowledge, and satisfaction

    Page :780

    Jeffrey J. Goldberger, Jane Kruse, Alan H. Kadish, Rod Passman, Daniel W. Bergner

    Résumé Résumé Plan Plan  
  • ·Training providers in hypertension guidelines: Cost-effectiveness evaluation of a continuing medical education program in South Carolina

    Page :786

    Justin G. Trogdon, Benjamin T. Allaire, Brent M. Egan, Daniel T. Lackland, Dory Masters

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Letter to the Editor regarding “Outcomes in patients with chronicity of left bundle-branch block with possible acute myocardial infarction”

    Page :e23

    Stephen W. Smith, Kenneth W. Dodd

    
  • ·Regarding “Depressive symptoms are related to progression of coronary calcium in midlife women: The Study of Women's Health Across the Nation (SWAN) Heart Study”

    Page :e25

    Carmine Pizzi, Grazia Maria Costa, Raffaele Bugiardini

    
  • ·Reply to Pizzi et al regarding “Depressive symptoms are related to progression of coronary calcium in midlife women: The Study of Women's Health Across the Nation (SWAN) Heart Study”

    Page :e27

    Imke Janssen, Lynda H. Powell, John F. Cursio, Karen A. Matthews, Steven M. Hollenberg, Kim Sutton-Tyrrell, Joyce T. Bromberger, Susan A. Everson-Rose